Alkindi approved in Australia

10 August 2020 - Diurnal Group announces that Alkindi (hydrocortisone granules in capsules for opening) has been approved by the ...

Read more →

SMC - August 2020 decisions

10 August 2020 - The Scottish Medicines Consortium has today published advice accepting neratinib (Nerlynx) for the treatment of breast ...

Read more →

U.S. Food and Drug Administration approves Lampit (nifurtimox) for the treatment of Chagas disease in children

7 August 2020 - Only Chagas disease treatment approved in U.S. for use in children from birth to less than 18 ...

Read more →

FDA approves new opioid for intravenous use in hospitals, other controlled clinical settings

7 August 2020 - Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management ...

Read more →

Rheumatoid arthritis drug Rinvoq gets insurance benefit

7 August 2020 - AbbVie Korea’s rheumatoid arthritis treatment Rinvoq (upadacitinib) has obtained the national health insurance benefit. ...

Read more →

FDA approves first liquid biopsy next generation sequencing companion diagnostic test

7 August 2020 - Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses ...

Read more →

FDA approves oral treatment for spinal muscular atrophy

7 August 2020 - The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age ...

Read more →

Novartis receives EC approval for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps

6 August 2020 - EC approves Xolair (omalizumab) as an add-on therapy for severe chronic rhinosinusitis with nasal polyps, the first ...

Read more →

Catalyst Pharmaceuticals’ Firdapse (amifampridine phosphate) receives marketing approval in Canada for patients with LEMS

6 August 2020 - Catalyst Pharmaceuticals today announced that Canada’s national health care regulatory agency, Health Canada, has approved the ...

Read more →

NICE supports use of new medicine for patients with malignant disease

5 August 2020 - Treosulphan is used as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation. ...

Read more →

Darolutamide in prostate cancer: indication of considerable added benefit

3 August 2020 - Advantages in overall survival, symptoms and health-related quality of life. ...

Read more →

FDA approves GSK’s Blenrep (belantamab mafodotin-blmf) for the treatment of patients with relapsed or refractory multiple myeloma

6 August 2020 - Blenrep is the fifth major medicine approval for GSK in 2020. ...

Read more →

Cimzia is the first and only biologic approved in Europe with the option for a reduced maintenance dose for patients across the full axial spondyloarthritis spectrum

5 August 2020 - European label extended to include a dose reduction option for the treatment of adult patients with axial ...

Read more →

NICE publishes draft guidance on the use of a topical gel by patients with a rare cancer

5 August 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using chlormethine gel ...

Read more →

Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patients

5 August 2020 - FDA granted de novo class II for cobas EBV test following the agency’s breakthrough device designation. ...

Read more →